International
Albania
Bosnia and Herzegovina
Bulgaria
Croatia
Czech Republic
Estonia
Hungary
Latvia
Lithuania
Kosovo
North Macedonia
Poland
Romania
Serbia
Slovakia
Slovenia
Switzerland (German)
Switzerland (French)
Media
Meet us
Careers
Contact
Business Development
Licensing
Strategic Therapeutic Areas
Territory
Partners & Brands
Testimonials
About Ewopharma
Vision/Mission
Our Values
Our Strategy
Leadership
Corporate Responsibility
Territory
Media
Meet us
Careers
Contact
International
Albania
Bosnia and Herzegovina
Bulgaria
Croatia
Czech Republic
Estonia
Hungary
Latvia
Lithuania
Kosovo
North Macedonia
Poland
Romania
Serbia
Slovakia
Slovenia
Switzerland (German)
Switzerland (French)
Media
PRESS RELEASES
Previous
1
2
3
4
Next
30.01.2024
Can-Fite Expands the Out-Licensing Deal with Ewopharma to Include the Pancreatic Cancer Indication
Read more
31.05.2023
Neomed s.r.o. becomes part of Ewopharma Group
Read more
29.04.2022
Calmino and Ewopharma join up to treat Irritable Bowel Syndrome (IBS)
Read more
17.05.2021
Neobiomics AB and Ewopharma AG announce an exclusive collaboration for distribution of ProPrems® in Switzerland
Read more
16.03.2021
Can-Fite Signs $42.7 Million Out-Licensing Deal with Ewopharma
Read more
Previous
1
2
3
4
Next
